Satavari and Ashoka for Menopause (SAM) Study
Vidya USA Corporation · with MusB Research · NCT07861295
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40–65 · Women only
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- October 1, 2025
- Record last updated
- October 6, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This 12-week randomized, placebo-controlled clinical trial will evaluate the efficacy and safety of a daily oral supplement containing Ashoka Bark and Shatavari in women experiencing menopausal symptoms. Up to 50 participants will be randomized to receive either the active supplement or placebo, with 40 participants expected to complete the study. Participants will attend visits at Weeks 0, 6, and 12, where hormone levels (FSH and estradiol), menopausal symptoms, quality of life, anxiety, cognitive function, and sleep will be assessed using validated measures. The study will also explore changes in the vaginal microbiome and monitor safety and adherence throughout the trial. The study will be conducted at MusB Research in New Port Richey, Florida.
Being studied: Ashoka Bark and Shatavari; Placebo
Conditions: Menopause
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Females aged 40-65 years.
- Postmenopausal women in good overall health and fulfilling menopausal criteria set at the MRS score more than 5.
- Subjects had experienced absence of regular menstrual cycle for at least 3 months.
- Willingness to sign consent, follow protocols and regimen intake, as well as maintain normal physical activity and follow study procedures.
Exclusion Criteria
- Not on Hormone Replacement Therapy (HRT) or had discontinued HRT at least 12 months before admission to the study.
- History of breast cancer,
- BMI ≥ 40mg/kg².
- Prior removal of both ovaries.
- Pregnancy, breastfeeding, or plans for pregnancy.
- History of breast or uterine cancer, including hyperplasia, endometrial carcinoma, or cervical neoplasia.
- Unstable medical conditions or clinically diagnosed depression requiring treatment.
- Self-reported drug or alcohol abuse.
- Allergy or sensitivity to herbal ingredients.
- Undiagnosed abnormal vaginal bleeding;
- A bilateral hysterectomy;
- History of chronic alcoholism,
- Medication hypersensitivity, or allergy to dietary supplement ingredients;
- Acute systemic infection or abnormal laboratory values.
- No antibiotics use in past 30 days.
- No regular probiotics use in past 30 days.
Recruiting US locations
MusB Research LLC
New Port Richey, FL 34653
Site contact: Prinicipal Investigator · 8134190781 · info@musbdiagnostics.com
Similar studies in Florida
All nutrition & metabolism studies in Florida →- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants
OPKO Health, Inc.
- Location
- Miami, FL
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1/Phase 2
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals
- Location
- Miami, FL + 4 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersEarly Phase 1
LpD3.5 Intervention Study in Older Adults- LISA-I Trial
University of South Florida
- Location
- Tampa, FL
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Boca Raton, FL + 121 other US sites
- Eligibility basics
- Ages 55+